{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T08:29:06Z","timestamp":1751617746341,"version":"3.28.0"},"reference-count":10,"publisher":"Elsevier BV","issue":"5","license":[{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2024,11,1]],"date-time":"2024-11-01T00:00:00Z","timestamp":1730419200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,7,31]],"date-time":"2024-07-31T00:00:00Z","timestamp":1722384000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.fr","clinicalkey.jp","journalofcardiologycases.com","clinicalkey.es","clinicalkey.com.au","clinicalkey.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Cardiology Cases"],"published-print":{"date-parts":[[2024,11]]},"DOI":"10.1016\/j.jccase.2024.07.006","type":"journal-article","created":{"date-parts":[[2024,8,14]],"date-time":"2024-08-14T21:10:19Z","timestamp":1723669819000},"page":"172-175","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"title":["Carfilzomib-induced pulmonary hypertension in a patient with multiple myeloma"],"prefix":"10.1016","volume":"30","author":[{"given":"Kosuke","family":"Uruno","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hiroyuki","family":"Iwano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Toshiaki","family":"Hayashi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ryosuke","family":"Hatano","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kaoru","family":"Komuro","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Kandoh","family":"Kawahatsu","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Takahiro","family":"Doi","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Satoshi","family":"Yuda","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.jccase.2024.07.006_bb0005","doi-asserted-by":"crossref","first-page":"564","DOI":"10.1111\/ejh.12749","article-title":"A practical review on carfilzomib in multiple myeloma","volume":"96","author":"Muchtar","year":"2016","journal-title":"Eur J Haematol"},{"key":"10.1016\/j.jccase.2024.07.006_bb0010","doi-asserted-by":"crossref","first-page":"2557","DOI":"10.1080\/10428194.2018.1437269","article-title":"Cardiotoxicity associated with carfilzomib: systematic review and meta-analysis","volume":"59","author":"Shah","year":"2018","journal-title":"Leuk Lymphoma"},{"key":"10.1016\/j.jccase.2024.07.006_bb0015","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1007\/s11912-019-0784-4","article-title":"Cardiovascular complications associated with multiple myeloma therapies: incidence, pathophysiology, and management","volume":"21","author":"Patel","year":"2019","journal-title":"Curr Oncol Rep"},{"key":"10.1016\/j.jccase.2024.07.006_bb0020","doi-asserted-by":"crossref","first-page":"808","DOI":"10.1002\/cncr.32601","article-title":"Measuring cardiopulmonary complications of carfilzomib treatment and associated risk factors using the SEER-Medicare database","volume":"126","author":"Fakhri","year":"2020","journal-title":"Cancer"},{"key":"10.1016\/j.jccase.2024.07.006_bb0025","doi-asserted-by":"crossref","first-page":"842","DOI":"10.1253\/circj.CJ-66-0158","article-title":"Guidelines for the treatment of pulmonary hypertension (JCS 2017\/JPCPHS 2017)","volume":"83","author":"Fukuda","year":"2019","journal-title":"Circ J"},{"key":"10.1016\/j.jccase.2024.07.006_bb0030","doi-asserted-by":"crossref","DOI":"10.1002\/pul2.12210","article-title":"Pulmonary hypertension in patients with multiple myeloma: a comprehensive review","volume":"13","author":"Maddipati","year":"2023","journal-title":"Pulm Circ"},{"key":"10.1016\/j.jccase.2024.07.006_bb0035","doi-asserted-by":"crossref","first-page":"782","DOI":"10.1200\/JCO.2014.55.5748","article-title":"Therapeutic landscape of carfilzomib and other modulators of the ubiquitin-proteasome pathway","volume":"33","author":"Mitsiades","year":"2015","journal-title":"J Clin Oncol"},{"key":"10.1016\/j.jccase.2024.07.006_bb0040","article-title":"Carfilzomib-induced pulmonary hypertension with associated right ventricular dysfunction: a case report","volume":"9","author":"McGregor","year":"2021","journal-title":"SAGE Open Med Case Rep"},{"key":"10.1016\/j.jccase.2024.07.006_bb0045","doi-asserted-by":"crossref","first-page":"296","DOI":"10.4103\/HEARTVIEWS.HEARTVIEWS_107_20","article-title":"Severe right-sided heart failure and pulmonary hypertension with carfilzomib treatment in multiple myeloma","volume":"21","author":"Mathur","year":"2020","journal-title":"Heart Views"},{"key":"10.1016\/j.jccase.2024.07.006_bb0050","doi-asserted-by":"crossref","DOI":"10.1177\/20458940211049300","article-title":"Carfilzomib-associated pulmonary arterial hypertension in multiple myeloma","volume":"11","author":"Yang","year":"2021","journal-title":"Pulm Circ"}],"container-title":["Journal of Cardiology Cases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878540924000744?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878540924000744?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2024,11,2]],"date-time":"2024-11-02T05:28:14Z","timestamp":1730525294000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878540924000744"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,11]]},"references-count":10,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2024,11]]}},"alternative-id":["S1878540924000744"],"URL":"https:\/\/doi.org\/10.1016\/j.jccase.2024.07.006","relation":{},"ISSN":["1878-5409"],"issn-type":[{"type":"print","value":"1878-5409"}],"subject":[],"published":{"date-parts":[[2024,11]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Carfilzomib-induced pulmonary hypertension in a patient with multiple myeloma","name":"articletitle","label":"Article Title"},{"value":"Journal of Cardiology Cases","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jccase.2024.07.006","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 Japanese College of Cardiology. Published by Elsevier Ltd.","name":"copyright","label":"Copyright"}]}}